sotorasib

Spain

Drugs containing this active substance

  • LUMYKRAS 240 MG FILM-COATED TABLETS

    It is used to treat adult patients with a type of lung cancer called non-small cell lung cancer (NSCLC) in advanced stages that has spread to other parts of the body, provided that the cancer cells have a specific genetic mutation (KRAS G12C) and previous treatments have not worked.

    Form: tablets, film-coated

    Active substance Dosage
    sotorasib 240 mg

    ATC: L01X L01XX L01XX73

    Manufacturer: Amgen Europe B.V.